Up to $45,000 of CSUPERB funds will be allocated for workshops or short-courses in the summer of 2009. CSUPERB will review proposals with budgets between $1,000 and $15,000. CSUPERB will consider only one proposal per PI to the Workshops and Short Courses Grant Program. However, investigators applying to the Workshops and Short Courses Grant Program may also apply to other CSUPERB Grant Programs. The Principal Investigator must be a tenured or tenure-track faculty member; however,  Ph.D. faculty other than tenured or tenure-track may be a Co-Principal Investigator.
     These proposals need not include an external match, but matching funds can in some situations be a measure of institutional commitment and support for the proposed project. Matching contributions may represent an investment of money, time, intellect and other resources towards a common goal. 

    Proposals are being sought to support new or established activities in the areas listed below. Interactions among disciplines and campuses should be considered as well as promotion of new academic-industry linkages.

 Workshops and short-courses related to:
     • faculty and staff enhancement
     • new or existing technologies and scientific innovations related to biotechnology
     • instrumental core resource facilities
     • interfaces between the sciences, engineering, the health sciences and business

CSUPERB considers the definition of biotechnology to be a diverse collection of technologies that capitalize on the attributes, and/or the manipulation, of organisms or tissues, or cellular, sub-cellular, or biomolecular components to discover new knowledge, to solve problems and/or to create models, goods, products, services, and/or therapies and ethical considerations thereof.

Such technologies include, but are not limited to*:

•	Nucleic acids (DNA/RNA): genomics, pharmacogenetics, gene probes, gene mapping, DNA sequencing/synthesis/amplification, PCR or PCR amplification, restriction length polymorphism analysis, genetic engineering (e.g. recombinant DNA, gene therapy, cloning, antisense), viral vectors and related technologies.
•	Peptide and Proteins: protein/peptide sequencing/synthesis, protein engineering, lipid/protein glycoengineering, proteomics, hormones, and growth factors, cell receptors/signaling/pheromones hybridoma technology (to produce monoclonal antibodies).
•	Chemistry and chemical biology: synthesis, medicinal chemistry, drug development, analytical/computational/combinatorial chemistry, or cheminformatics of nucleic acids, peptides and proteins, or other biologically-relevant molecules related to the above technologies.
•	Cell and tissue culture and engineering: cell/tissue culture, tissue engineering, hybridization, cellular fusion, vaccine/immune stimulants, embryo manipulation, gene therapy.
•	Process biotechnologies: bioreactors, fermentation, bioprocessing, bioleaching, bio-pulping, bio-bleaching, biodesulphurization, bioremediation, and biofiltration.
•	Biomaterials and Biomedical Devices: biocompatability of materials for implants and biomedical devices with preference given to development and testing of therapeutic devices, environmental monitoring, and biosensors.

*For a more comprehensive list, please see, List of Biotechnologies and Biotechnological Processes

Dr. Mina Hector

Director of Education, CSUPERB

mhector@csuchico.edu

619-594-2822